Taurine in 24-h urine samples is inversely related to cardiovascular risks of middle aged subjects in 50 populations of the world

Advances in Experimental Medicine and Biology

Volumn 803, Issue , 2015, Pages 623-636

  Sagara, Miki ^a   Murakami, Shigeru ^b   Mizushima, Shunsaku ^c   Liu, Longjian ^d   Mori, Mari ^e   Ikeda, Katsumi ^e   Nara, Yasuo ^a   Yamori, Yukio ^a,e  

^a RESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT   (Japan)

^b FUKUI PREFECTURAL UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d DREXEL UNIVERSITY   (United States)

^e MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; TAURINE;

ADULT; AGE; AMINO ACID URINE LEVEL; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG USE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX; SYSTOLIC BLOOD PRESSURE; URINALYSIS; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; GEOGRAPHY; HEALTH; MULTICENTER STUDY; POPULATION; PROCEDURES; URINE;

CARDIOVASCULAR DISEASES; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; GEOGRAPHY; GLOBAL HEALTH; HUMANS; MALE; MIDDLE AGED; POPULATION; RISK FACTORS; TAURINE; URINALYSIS;

EID: 84926670167     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-15126-7_50     Document Type: Article

References (36)

1. Fujihira E, Takahashi H, Nakazawa M (1970) Effect of long-term feeding of taurine in hereditary hyperglycemic obese mice. Chem Pharm Bull 18:1636–1642
2. Fujita T, Sato Y (1986) Changes in blood pressure and extracellular fluid with taurine in DOCAsalt rats. Am J Physiol 250:R1014–R1020
3. Fujita T, Ando K, Noda H, Ito Y, Sato Y (1987) Effects of adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation 75:525–532
4. Fukuda M, Yamori Y (1987) A proposal for indirect and objective blood pressure measurement in adults. In: Yamori Y, Lenfant C (eds) Prevention of cardiovascular diseases: an approach to active long life. Elsevier, Amsterdam, pp 127–137
5. Gokce G, Ozsarlak-Sozer G, Oran I, Oktay G, Ozkal S, Kerry Z (2011) Taurine suppresses oxidative stress-potentiated expression of lectin-like oxidized low-density lipoprotein receptor and restenosis in balloon-injured rabbit iliac artery. Clin Exp Pharmacol Physiol 38:811–818
6. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101–163
7. Iantorno M, Campia U, Di Damiele N, Nistico S, Forleo GB, Cardillo C, Tesauro M (2014) Obesity, inflammation and endothelial dysfunction. Int J Immunopathol Pharmacol 28:169–176
8. Kim C, Cha YN (2014) Taurine chloramine produced from taurine under inflammation provides anti-inflammatory and cytoprotective effects. Amino Acids 46:89–100
9. Li N, Sawamura M, Nara Y, Ikeda K, Yamori Y (1996) Direct inhibitory effect of taurine or norepinephrine- induced contraction in mesenteric artery of stroke-prone spontaneously hypertensive rats. Adv Exp Med Biol 403:257–262
10. McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson JE, Hasani M, Volkova E, Kazmi K, Yusuf S, INTERHEART study investigators (2008) Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 372:224–233
11. Mizushima S, Nara Y, Sawamura M, Yamori Y (1996) Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv Exp Med Biol 403:615–622
12. Murakami S (2014) Taurine and atherosclerosis. Amino Acids 46:73–80
13. Murakami S, Yamagishi I, Asami Y, Ohta Y, Toda Y, Nara Y, Yamori Y (1996) Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats. Pharmacology 52:303–313
14. Murakami S, Kondo Y, Sakurai T, Kitajima H, Nagate T (2002a) Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis 163:79–87
15. Murakami S, Kondo Y, Toda Y, Kitajima H, Kameo K, Sakono M, Fukuda N (2002b) Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci 70:2355–2366
16. Murakami S, Sakurai T, Tomoike H, Sakono M, Nasu T, Fukuda N (2010) Prevention of hypercholesterolemia and atherosclerosis in the hyperlipidemia- and atherosclerosis-prone Japanese (LAP) quail by taurine supplementation. Amino Acids 38:271–278
17. Nara Y, Yamori Y, Lovenberg W (1978) Effect of dietary taurine on blood pressure in spontaneously hypertensive rats. Biochem Pharmacol 27:2689–2692
18. Okamoto K, Aoki K (1963) Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27:282–293
19. Okamoto T, Yamori Y, Nagaoka A (1974) Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res 34(35):143–153
20. Rasa FT, Freitas EC, Deninic R, Jordão AA, Marchini JS (2014) Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study. Eur J Nutr 53:823–830
21. Tsuboyama-Kasaoka N, Shozawa C, Sano K, Kamei Y, Kasaoka S, Hosokawa Y, Ezaki O (2006) Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. Endocrinology 147:3276–3284
22. WHO-CARDIAC Study Group (1986) Cardiovascular Diseases and Alimentary Comparison (CARDIAC) Study protocol and manual of operations. WHO Collaborating Center on Primary Prevention of Cardiovascular Diseases, Izumo, Japan and Cardiovascular Diseases Unit, WHO, Geneva
23. WHO-CARDIAC Study group (1990) Excerpts from the WHO CARDIAC Study Protocol. J Cardiovasc Pharmacol 16(Suppl 8):S75–S77
24. Yamori Y (1984a) Development of the spontaneously hypertensive rat (SHR) and of various spontaneous rat models, and their implications. In: De Jong W (ed) Handbook of hypertension. Elsevier, Amsterdam, pp 224–239
25. Yamori Y (1984b) The stroke-prone spontaneously hypertensive rat: contribution to risk factor analysis and prevention of hypertensive diseases. In: De Jong W (ed) Handbook of hypertension. Elsevier, Amsterdam, pp 240–255
26. Yamori Y (1989) Predictive and preventive pathology of cardiovascular diseases. Acta Pathol Jpn 39:683–705
27. Yamori Y, Nara Y, Kihara M, Mano M, Horie R (1984) Simple method for sampling consecutive 24-hour urine for epidemiological and clinical studies. Clin Exp Hypertens A 6:1161–1167
28. Yamori Y, Nara Y, Mizushima S, Mano M, Sawamura M, Kihara M, Horie R (1990) International cooperative study on the relationship between dietary factors and blood pressure: a report from the Cardiovascular Diseases and Alimentary Comparison (CARDIAC) Study. J Cardiovasc Pharmacol 16(Suppl 8):S43–S47
29. Yamori Y, Nara Y, Ikeda K, Mizushima S (1996) Is taurine a preventive nutritional factor of cardiovascular diseases or just a biological marker of nutrition? Adv Exp Med Biol 403:623–629
30. Yamori Y, Liu L, Ikeda K, Miura A, Mizushima S, Miki T, Nara Y, WHO-Cardiovascular Disease and Alimentary Comparison (CARDIAC) Study Group (2001) Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens Res 24(4):453–457
31. Yamori Y, Liu L, Mizushima S, Ikeda K, Nara Y, CARDIAC Study Group (2006) Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries. J Hypertens 24:1499–1505
32. Yamori Y, Liu L, Mori M, Sagara M, Murakami S, Nara Y, Mizushima S (2009) Taurine as the nutritional factor for the longevity of the Japanese revealed by a world-wide epidemiological survey. Adv Exp Med Biol 643:13–25
33. Yamori Y, Taguchi T, Hamada A, Kunimasa K, Mori H, Mori M (2010a) Taurine in health and diseases consistent evidence from experimental and epidemiological studies. J Biomed Sci 17(Suppl 2):S6
34. Yamori Y, Taguchi T, Mori H, Mori M (2010b) Low cardiovascular risks in the middle aged males and females excreting greater 24-hour urinary taurine and magnesium in 41 WHO-CARDIAC study populations in the world. J Biomed Sci 17(Suppl 1):S21
35. Yokogoshi H, Mochizuki H, Nanami K, Hida Y, Miyachi F, Oda H (1999) Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J Nutr 129:1705–1712
36. Zhang M, Bi LF, Fang JH, Su XL, Da GL, Kuwamori T, Kagamimori S (2004) Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids 26:267–271